BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Clinical Outcome
6 results:

  • 1. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
    García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
    Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis.
    Zhou R; Wei C; Liu J; Luo Y; Tang W
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():210-213. PubMed ID: 26595307
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With clinical outcomes.
    Hussein YR; Ducie JA; Arnold AG; Kauff ND; Vargas-Alvarez HA; Sala E; Levine DA; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):404-9. PubMed ID: 26574845
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. brca1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
    Lesnock JL; Darcy KM; Tian C; Deloia JA; Thrall MM; Zahn C; Armstrong DK; Birrer MJ; Krivak TC
    Br J Cancer; 2013 Apr; 108(6):1231-7. PubMed ID: 23462720
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. brca1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma.
    Beirne JP; Quinn JE; Maxwell P; Kalloger SE; McAlpine J; Gilks CB; Harley IJ; McCluggage WG
    Int J Gynecol Cancer; 2013 Jan; 23(1):113-8. PubMed ID: 23221734
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.
    Narayan G; Arias-Pulido H; Koul S; Vargas H; Zhang FF; Villella J; Schneider A; Terry MB; Mansukhani M; Murty VV
    Mol Cancer; 2003 May; 2():24. PubMed ID: 12773202
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.